Lower radiation dose to the vagina during brachytherapy for cervical cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This study tests whether giving a lower radiation dose to the vagina during brachytherapy (internal radiation) is safe and works as well as the standard dose for people with cervical cancer that has not spread to the vagina. It aims to reduce side effects while still treating the cancer effectively.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been newly diagnosed with cervical cancer (a type called adenocarcinoma or squamous cell carcinoma).
- Your cancer is at an early to locally advanced stage (stage I–III), and does not involve the vagina.
- If your cancer has spread to a few other spots (up to 4), they can be treated with curative intent.
- Your overall health allows you to be up and about (ECOG score 0–2).
- Your treatment plan includes external beam radiation (with or without chemotherapy) followed by brachytherapy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a feasibility (“can it be done safely?”) approach that delivers radiation in a shorter schedule for some cervical cancer patients. It also uses weekly cisplatin chemotherapy and includes a radiation procedure called brachytherapy to improve treatment effectiveness.
This study tests image-guided internal radiation (brachytherapy) for certain gynecologic cancers. It may help deliver radiation more precisely by using scans done close to enrollment.
This study looks at how cervical cancer and radiation therapy affect the body. It aims to understand why side effects happen, which could lead to better treatment in the future.
This trial studies a shorter, focused radiation schedule given after surgery for certain higher-risk cervical or endometrial (uterine) cancers. It may help reduce cancer recurrence while checking side effects in the bladder and bowel area.
This study is testing a special type of internal radiation (called image-guided brachytherapy) for women with vaginal cancer. It aims to give high doses directly to the tumor while limiting side effects to nearby organs.
This trial tests a way to measure the exact radiation dose you receive during internal radiotherapy (brachytherapy). It aims to make treatment safer and more effective for prostate or gynecologic cancers.
Hear when a new Cervical Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.